Articles about immunotherapy – Page 2 of 3

Inside Seattle Children’s landmark $1B campaign to cure childhood cancer and other diseases

It’s an exciting time to be studying cures for cancer. New technology like cutting-edge immunotherapy treatments are opening doors to… Read More

New immunotherapy study aims to prevent children with leukemia from relapsing

When scientists at Seattle Children’s Research Institute began studying a new immunotherapy cancer treatment a few years ago, they found… Read More

Seattle Children’s launches $1 billion campaign with plans to build new immunotherapy research center

Seattle Children’s, a hospital and research institute focused on curing childhood diseases, is kickstarting the biggest campaign in its 110-year… Read More

Immunotherapy is safe for those with HIV, study says, opening new treatments to patients in need

People with HIV or AIDS are at a much higher risk of developing and dying from cancer — in fact, cancer… Read More

Scientists discover stem cells behind bone marrow transplants, pointing the way to new cancer treatments

For decades, bone marrow transplants have been a crucial treatment for blood cancers like leukemia and lymphoma — but scientists… Read More

New study could point to solution for deadly immunotherapy side effects

CAR T immunotherapies — which genetically program immune cells to fight cancer — hold incredible promise for cancer patients who… Read More

Juno Therapeutics’ giant new Seattle HQ is designed to destroy cancer

When you walk into Juno Therapeutics‘ new headquarters in Seattle, your eyes are immediately drawn to the view. The office’s… Read More

Fred Hutch licenses new immunotherapy treatment to Mustang Bio, preps clinical trials in Seattle

A new immunotherapy technology developed at Seattle’s Fred Hutchinson Cancer Research Center has been licensed to New York-based Mustang Bio,… Read More

New ‘hit-and-run’ gene editing tool temporarily rewrites genetics to treat cancer and HIV

CAR T immunotherapies are all the rage in the medical community, reprogramming a patient’s immune system to fight cancer. For… Read More

Juno Therapeutics stock jumps 40% as rival Kite Pharma reaches deal to be acquired for $11.9B

Seattle’s Juno Therapeutics, a biotech company developing cutting edge CAR T immunotherapies for cancer, faces a narrow field of competitors. Few… Read More

Juno Therapeutics posts mixed results, remains optimistic about treatment pipeline

Seattle-based biotech company Juno Therapeutics beat analyst expectations in its second quarter revenue Thursday, reporting $21.3 million in revenue for… Read More

Seattle Genetics discontinues trials of cancer drug, sees stock losses

Seattle Genetics, a Bothell, Wash., based biotechnology company developing novel treatments for cancer, announced Monday that it has discontinued the… Read More

Juno Therapeutics’ revenue surges on Celgene partnership, loss increases on R&D spending

Seattle-based biotech juggernaut Juno Therapeutics delivered mixed results in its 2017 quarter one earnings report Thursday — the first financial report… Read More

Seattle Genetics reports $109M in quarterly revenue, narrowly beating expectations

Seattle-based biotech company Seattle Genetics announced a revenue of $109 million for the first quarter of 2017 Thursday, narrowly beating… Read More

Fred Hutch Study: Novel immunotherapy tech made tumors shrink, a good sign for future treatments

Immunotherapy — treatments that harness the body’s immune system to fight cancer — have seen promising results in blood cancers like… Read More

Filings show Juno executives took hits to their compensation following failed clinical trial

This time last year, Seattle biotech company Juno Therapeutics was on its way to having the first CAR T immunotherapy… Read More

Biotech standout Juno plans Bay Area office, hires ex-Genentech exec as R&D president

Juno Therapeutics announced Monday that a former Genentech executive, Dr. Sunil Agarwal, has joined the company as its new President of… Read More

Fred Hutch study: New nanoparticle immunotherapy could replace chemo as front-line cancer treatment

Dr. Matthias Stephan has a vision: cancer-killing immunotherapy that is so cheap and easy to access it replaces chemotherapy as the… Read More

Q&A: Cancer research leader Nancy Davidson on the innovations of the past decade, and where things are heading next

We often hear that medical research is approaching “breakthroughs” or is at a “tipping point” in innovation. But what does… Read More

Fred Hutch study: Cancer drug inspired by bacteria could boost immunotherapy treatments

When we think of the immune system, we generally think of one, unified system that works to fight infections and… Read More

Bezos family makes record-breaking $35M donation to Fred Hutch to fund cancer research

The Fred Hutchinson Cancer Research Center announced today that it has received a $35 million gift from the Bezos family, the… Read More

Juno Therapeutics beats earnings expectations, announces it will drop problem cancer drug

Seattle-based cancer immunotherapy company Juno Therapeutics handily beat analyst expectations for the fourth quarter, posting $21.2 million in revenue, compared to… Read More

Fred Hutch study discovers rare set of cells that are highly effective at fighting cancer

If the immune system is an army, then T-cells are soldiers on the front lines, attacking invading viruses and other… Read More

Neurosurgery professor raises cash for stealthy biotech startup Silverback Therapeutics

Silverback Therapeutics, a stealthy biotech startup co-founded by investor, entrepreneur and University of Washington neurosurgery professor Peter Thompson, has raised $10… Read More

Could immunotherapy cure HIV? $2.6M grant will help Fred Hutch researcher find out

Immunotherapy — using the body’s immune system to fight disease — has already made great strides in cancer treatment, with the Seattle… Read More

A first look inside the cutting-edge Bezos Family Immunotherapy Clinic

Stephanie Florence is the image of optimism. She is a blonde, bubbly, professional photographer from Lewiston, Idaho, who has a… Read More

Juno study shows 60 percent of lymphoma patients in remission after immunotherapy treatment

New data from Seattle’s Juno Therapeutics shows promising results for one of its immunotherapy treatments, JCAR017. The drug was studied as a treatment… Read More

Fred Hutch research shows immunotherapy could prevent Leukemia patients from relapsing

For decades, bone marrow transplants have been an integral treatment for patients with Leukemia and other blood diseases. And now,… Read More

Juno’s flagship cancer treatment faces new uncertainty, highlighting risks of immunotherapy

Juno Therapeutics announced last week that it was placing a voluntary hold on its clinical trial of JCAR015 — an… Read More

Juno stock plunges as additional deaths cause second hold on clinical trial for leukemia treatment

Juno Therapeutics, the Seattle-based biotech company developing immunotherapy treatments for cancer, announced it has placed a voluntary hold on the clinical… Read More